Overview

• The input is a grouped list of antidepressant drug names and mnemonics. These notes extract the listed drugs, map major examples to common drug classes, and highlight key clinical points (mechanisms, side effects, interactions, switching rules).

Original grouped list (from input)

1. Antidepressants (mnemonics): AAAA, CCD, EEE, FLL, LMN, NPP, PPP, RSS, TTVW
2. TNE: Tofranil, Norpramin, Elavil
3. AAAV: Aventyl, Adapin, Anafranil, Vivactil
4. PPPP: Pamelor, Prozac, Pristiq, Paxil
5. SSS: Surmontil, Sarafem, Sinequan
6. LLL: Ludiomil, Lexapro, Luvox
7. VW: Vilbryd, Wellbutrin XL
8. ZPE: Zoloft, Parnate, Effexor XR
9. CR: Celexa, Remeron
10. LD: Desyrel
11. NE: Nardil, Emsam patch

(Note: the list mixes brand names and brand-specific products; some entries are alternate brands for the same generic.)

Key antidepressant classes (with examples from the list)

• SSRIs (selective serotonin reuptake inhibitors) — increase serotonin by blocking reuptake.
• Examples from list: Prozac (fluoxetine), Zoloft (sertraline), Paxil (paroxetine), Celexa (citalopram), Lexapro (escitalopram), Luvox (fluvoxamine), Sarafem (brand of fluoxetine).

• Typical adverse effects: sexual dysfunction, GI upset, insomnia or somnolence, possible weight change.

• SNRIs (serotonin–norepinephrine reuptake inhibitors) — block serotonin and norepinephrine reuptake.

• Examples: Effexor XR (venlafaxine), Pristiq (desvenlafaxine).

• Key issues: can raise blood pressure (esp. venlafaxine), similar sexual side effects as SSRIs.

• TCAs (tricyclic antidepressants) — older class, affect multiple monoamine systems and have strong anticholinergic effects.

• Examples from list: Tofranil (imipramine), Norpramin (desipramine), Elavil (amitriptyline), Anafranil (clomipramine), Pamelor (nortriptyline), Sinequan (doxepin), Surmontil (trimipramine), Vivactil (protriptyline), Adapin (doxepin brand).

• Typical adverse effects: anticholinergic effects (dry mouth, constipation), orthostatic hypotension, sedation, cardiotoxicity in overdose.

• MAOIs (monoamine oxidase inhibitors) — inhibit MAO enzymes; dietary and drug interactions are important.

• Examples: Nardil (phenelzine), Parnate (tranylcypromine), Emsam (selegiline transdermal patch).

• Key warnings: risk of hypertensive crisis with tyramine-rich foods; many drug interactions; require washout periods when switching.

• Atypical / other mechanisms

• Bupropion (Wellbutrin XL) — NDRI (norepinephrine–dopamine reuptake inhibitor); less sexual dysfunction, but lowers seizure threshold.
• Mirtazapine (Remeron) — NaSSA (noradrenergic and specific serotonergic antidepressant); sedating and can increase appetite/weight.
• Trazodone (Desyrel) — SARI (serotonin antagonist and reuptake inhibitor); often used for insomnia at low doses; risk of priapism rare but serious.
• Vilazodone (Vilbryd) — SSRI + 5-HT1A partial agonist; similar SSRI effects with some unique receptor activity.

Practical clinical points

• Choosing a class: SSRIs/SNRIs are first-line for many depressive disorders; TCAs and MAOIs used when others fail or for specific indications.
• Side-effect profiles (high-level):
• SSRIs/SNRIs: sexual dysfunction, GI symptoms, insomnia or somnolence.
• TCAs: anticholinergic effects, sedation, orthostatic hypotension, cardiotoxicity in overdose.
• MAOIs: dietary tyramine interactions, many drug interactions, hypertensive crisis risk.
• Bupropion: stimulatory effects, lowers seizure threshold.
• Mirtazapine: sedation, increased appetite/weight gain.
• Serotonin syndrome: risk when combining serotonergic drugs (SSRI + MAOI, SSRI + SNRI + triptans, etc.). Symptoms include agitation, autonomic instability, hyperreflexia, clonus.
• Switching rules (essential practical point):
• Allow a washout period when switching from an MAOI to most other antidepressants (commonly ~14 days); fluoxetine requires a longer washout (about 5 weeks) because of its long half-life.
• Conversely, avoid starting MAOIs soon after stopping serotonergic drugs.
• Monitoring: blood pressure (SNRIs, MAOIs), mood/suicidality (all antidepressants, especially early), ECG and overdose risk with TCAs, weight and metabolic effects for some drugs.

Quick-reference: notable drugs and one-line notes

• Fluoxetine (Prozac / Sarafem): SSRI; long half-life; fluoxetine brand used for PMDD (Sarafem).
• Sertraline (Zoloft): SSRI; commonly used, well tolerated.
• Paroxetine (Paxil): SSRI; anticholinergic and withdrawal issues.
• Citalopram (Celexa), Escitalopram (Lexapro): SSRIs; generally well tolerated.
• Venlafaxine (Effexor XR), Desvenlafaxine (Pristiq): SNRIs; watch BP.
• Bupropion (Wellbutrin XL): NDRI; less sexual dysfunction, seizure risk at high doses.
• Trazodone (Desyrel): sedating antidepressant, used off-label for insomnia.
• Mirtazapine (Remeron): sedating, increases appetite.
• Imipramine (Tofranil), Amitriptyline (Elavil), Nortriptyline (Pamelor), Desipramine (Norpramin): TCAs; many side effects, overdose risk.
• Clomipramine (Anafranil): TCA with strong serotonergic activity (used for OCD).
• Phenelzine (Nardil), Tranylcypromine (Parnate), Selegiline patch (Emsam): MAOIs; serious interactions, last-line but effective for some cases.

Safety reminders and study tips

• Memorize major classes and 3–5 representative drugs for each class.
• Always think: SSRIs/SNRIs (first-line) → TCAs/MAOIs (older; special uses) → Atypicals (tailored to side-effect needs).
• Remember washout periods and serotonin syndrome as high-yield clinical warnings.
• Use mnemonics in the input as cues, but cross-check brand/generic names when prescribing or studying.

Quick checklist for exams/clinically relevant recall

• Which drugs are SSRIs? (Prozac, Zoloft, Paxil, Celexa, Lexapro, Luvox)
• Which are TCAs? (Tofranil, Elavil, Pamelor, Norpramin, Sinequan, Surmontil)
• Which are MAOIs? (Nardil, Parnate, Emsam)
• Atypical examples and unique cautions: Wellbutrin (seizures), Mirtazapine (weight/sedation), Trazodone (sedation/priapism).